Abbott Laboratories (ABT) Acquisitions (2009 - 2019)

Abbott Laboratories' Acquisitions history runs 11 years deep, the most recent figure standing at $82.0 million for Q2 2019.

• In Q2 2019, Acquisitions rose 355.56% year-over-year to $82.0 million; the TTM figure through Jun 2019 stood at $203.0 million (down 95.17% YoY), while the FY2017 annual figure was $17.2 billion, up 21378.75% from the prior year.
• Acquisitions came in at $82.0 million for Q2 2019 at Abbott Laboratories, up from $78.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $13.0 billion in Q1 2017 to a low of $7.0 million in Q4 2016.
• A 5-year average of $2.0 billion and a median of $78.0 million in 2019 frame the typical range for Acquisitions.
• Across the five-year window, Acquisitions soared 59271.43% in 2017 and sank 99.81% in 2018, its largest moves.
• Abbott Laboratories' Acquisitions stood at $231.0 million in 2015, then plunged by 96.97% to $7.0 million in 2016, then jumped by 59271.43% to $4.2 billion in 2017, then plunged by 99.57% to $18.0 million in 2018, then soared by 355.56% to $82.0 million in 2019.
• According to Business Quant data, Acquisitions over the past three periods registered $82.0 million, $78.0 million, and $18.0 million for Q2 2019, Q1 2019, and Q2 2018 respectively.

Peer Comparison